Improved CRISPR base editing shows safer embryo gene editing, but major ethical questions remain
By
Michael Le Page
If you only eat one bagel today, this is the bagel.
Summary
A US team has used an improved CRISPR technique called base editing to edit human embryos without introducing harmful mutations, marking a potential safety advance over the controversial 2018 Chinese experiment. However, the article notes that a major ethical and safety issue remains unresolved, suggesting that while the technical risks may be decreasing, the debate over gene-editing babies is far from settled.
Key quotes
· 3 pulledWhen a rogue researcher in China revealed in 2018 that he had used CRISPR to create three gene-edited children, his actions were almost universally condemned by biologists around the world.
The main objection was not that gene-editing babies is wrong in itself, but that the CRISPR technique used was not safe and had a very high risk of causing harmful mutations.
Now, a team in the US has used an improved form of CRISPR, known as base editing, to edit healthy embryos and shown that it can be done without introducing unwanted mutations.
You might also wanna read
First In-Vivo Gene-Editing Therapy Successfully Saves Newborn's Life in 2025
In 2025, doctors and scientists in the U.S. successfully performed the world's first custom gene-editing therapy inside a living person—a ne
CRISPR-Enhanced Fungus Offers Sustainable Meat Alternative with Improved Nutrition
Researchers have used CRISPR gene editing to enhance Fusarium venenatum, a naturally meat-like fungus, making it more efficient, nutritious,
CRISPR's Limitations in Mitochondrial DNA Editing and Emerging Alternatives
The article discusses the limitations of CRISPR gene editing technology in accessing mitochondrial DNA (mtDNA) and the resulting challenges
CRISPR takes a bold leap toward silencing Down syndrome's extra chromosome
Using CRISPR-Cas9 for Trisomic Rescue in Down Syndrome Cells
The study demonstrates the use of CRISPR-Cas9 to achieve trisomy rescue by eliminating the target chromosome from human trisomy 21 cells.
